Understanding the Tumor Microenvironment of Cholangiocarcinoma
April 7th 2022The authors found that the relationship between immunosuppressive cells and effector T cells in hilar and distal cholangiocarcinoma has important implications for treatment, in that the tumor microenvironment would likely need to be primed for a treatment strategy to be effective.
Read More
Protease Inhibitor–Based ART Associated With Babies Born Small or Very Small
April 6th 2022A large systematic review on pregnant women living with HIV found that protease inhibitor–based antiretroviral therapy (ART) use was associated with increased risk of babies being born small or very small for their gestational age, but not with other adverse pregnancy outcomes.
Read More
Consider Screening Patients With Food Allergy for EoE, Pilot Study Says
April 6th 2022A recent study found a correlation in patients with an IgE-mediated food allergy (IgE-FA) reporting symptoms of eosinophilic esophagitis (EoE), leading researchers to conclude screening for EoE may be beneficial.
Read More
Dr Dennis Scanlon on Barriers for Learning Health Care Systems
April 6th 2022Dennis P. Scanlon, PhD, professor of health policy and administration at Pennsylvania State University and editor-in-chief of The American Journal of Accountable Care®, talks about major systemic and fundamental barriers to health systems becoming learning health systems.
Watch
Real-world Data Show Benefits of Increased Lung Cancer Screening but Persistent Disparities
April 6th 2022Although the widespread use of low dose computed tomography screening for lung cancer has led to improved mortality in recent years, disparities in uptake persist throughout the United States.
Read More
What We’re Reading: Long COVID-19 Research; Oklahoma Abortion Ban; Walgreens Opioid Lawsuit
April 6th 2022President Joe Biden announced plans to increase research on long COVID-19; the Oklahoma House voted 70-14 in favor of a near-total abortion ban; Walgreens is going to trial in Florida’s opioid epidemic lawsuit.
Read More
Dr Marc-Andre Cornier Discusses COVID-19's Impact on a Weight Loss Intervention Program
April 6th 2022Marc-Andre Cornier, MD, professor and director of the Division of Endocrinology, Diabetes and Metabolic Diseases at the Medical University of South Carolina, explains recent research on a behavioral weight loss intervention.
Watch
Baricitinib Linked With Improved Skin Pain Severity, Positive QOL in Atopic Dermatitis
April 5th 2022Patients with atopic dermatitis who achieved rapid changes in skin pain severity with the Janus kinase inhibitor baricitinib were associated with clinically significant improvement in Dermatology Life Quality Index scores.
Read More
What We're Reading: ACA Coverage Expansion; New Heart Failure Guidelines; Poor Air Quality Worldwide
April 5th 2022The Biden administration plans to expand Affordable Care Act (ACA) coverage to more families; new guidelines jointly announced by cardiology organizations for the treatment and prevention of heart failure; World Health Organization estimates that 99% of people worldwide are exposed to poor air quality.
Read More
Study Highlights Gaps in Awareness of COPD Pulmonary Rehabilitation
April 5th 2022A small study conducted in Melbourne, Australia, found that older age and being from a culturally and linguistically diverse community were associated with less awareness of pulmonary rehabilitation among patients with chronic obstructive pulmonary disease (COPD).
Read More
Examining the Impact of Psoriasis Disease Burden on QOL, Mental Health
April 4th 2022Two abstracts presented at the 2022 American Academy of Dermatology (AAD) Annual Meeting explored the health-related quality of life (QOL) and mental health impact of psoriasis disease burden by severity and affected body region.
Read More
Medicare Must Address High ART Costs, Investigators Argue
April 4th 2022With more people living with HIV now reaching advanced ages and qualifying for Medicare coverage, this new study investigated HIV-related influences on their health care spending, particularly antiretroviral therapy (ART), compared with a population who does not have HIV.
Read More
EMPULSE: Empagliflozin Yields QOL Benefits in Patients Hospitalized for Acute HF
April 4th 2022Patients hospitalized for acute heart failure and prescribed empagliflozin saw improvements in quality of life at 15 and 90 days post-discharge. The study may make the case for prescribing SGLT2 inhibitors before patients leave the hospital.
Read More
Sharpless Steps Down as NCI Director
April 4th 2022Norman E. “Ned” Sharpless, MD, is departing shortly after the launch of Cancer Moonshot 2.0, an initiative that aims to reduce the cancer death rate by at least half over the next 25 years while improving the experience for all those affected by cancer.
Read More